Pengpeng Zhang

机构：Shanghai International Studies University, Central South University, Tianjin Medical University Cancer Institute and Hospital, Third Xiangya Hospital, Hangzhou Medical College · ORCID：0000-0003-1488-265X

发表论文 179 篇 · 总被引 4513 次 · h-index 37

代表论文

• iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction (2025 · iMeta · 被引 129)
• The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy (2025 · EBioMedicine · 被引 36)
• Deubiquitination by USP7 Stabilizes JunD and Activates AIFM2 (FSP1) to Inhibit Ferroptosis in Melanoma (2025 · Journal of Investigative Dermatology · 被引 17)
• Nanoparticle-based strategy in CAR-T cell immunotherapy: challenges, implications, and perspectives (2025 · Molecular Cancer · 被引 15)
• Novel ATR/PARP1 Dual Inhibitors Demonstrate Synergistic Antitumor Efficacy in Triple‐Negative Breast Cancer Models (2025 · Advanced Science · 被引 12)
• A novel PARP-ATR dual inhibitor exhibits anti-triple-negative breast cancer activity by inducing excessive DNA damage in the mitotic phase (2025 · Biochemical Pharmacology · 被引 9)